ReviewFrontiers in molecular biosciences2023

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics.

Prashant Kumar Tiwari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.